Dresden Glaucoma and Treatment Study (DGTS)

NCT ID: NCT02959242

Last Updated: 2025-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to evaluate the quality of follow-up and treatment by means of consecutive data collection and anonymised analysis of all glaucoma patients of a tertiary university hospital glaucoma service.

Parameters being analyzed are:

Age, sex, refraction, family history, known duration of glaucoma, highest intraocular pressure before treatment, systemic and topical medication, previous ocular surgery.

24h Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph (HRT), glaucoma diagnosis with Scanning-Laser-Polarimetry (GDx), optical coherence tomography (OCT), Pentacam, Ocular Response Analyzer (ORA), Corvis ST (Corneal Visualization with the Scheimpflug Technology), perimetry

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Glaucoma, Open-Angle Glaucoma, Angle-Closure Glaucoma, Low Tension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* manifest glaucoma, ocular Hypertension, glaucoma suspect

Exclusion Criteria

* under 18 years of age, corneal diseases
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technische Universität Dresden

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Karin Pillunat

Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lutz E Pillunat, MD, PhD

Role: STUDY_DIRECTOR

Medical faculty of the Technical University of Dresden, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Eye Hospital, Medical Faculty, Technical University Dresden

Dresden, Saxony, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Karin R Pillunat, MD

Role: CONTACT

+49 351 458 3274

Lutz E Pillunat, MD, PhD

Role: CONTACT

+49 351 458 3381

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Karin R Pillunat, MD

Role: primary

+49 351 458 ext. 3274

Lutz E Pillunat, MD, PhD

Role: backup

+49 351 458 ext. 3381

References

Explore related publications, articles, or registry entries linked to this study.

Pillunat KR, Herber R, Jamke M, Jasper CS, Haase MA, Manseck AS, Pillunat LE. Early Results of Preserflo MicroShunt for Primary Open Angle Glaucoma in White Patients. J Glaucoma. 2025 Feb 1;34(2):103-113. doi: 10.1097/IJG.0000000000002509. Epub 2024 Oct 11.

Reference Type DERIVED
PMID: 39401481 (View on PubMed)

Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR. PRESERFLO MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):2901-2915. doi: 10.1007/s00417-023-06075-4. Epub 2023 May 3.

Reference Type DERIVED
PMID: 37133501 (View on PubMed)

Pillunat KR, Kocket GA, Herber R, Jasper CS, Lenk J, Pillunat LE. Efficacy of selective laser trabeculoplasty on lowering intraocular pressure fluctuations and nocturnal peak intraocular pressure in treated primary open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1979-1985. doi: 10.1007/s00417-022-05897-y. Epub 2022 Nov 23.

Reference Type DERIVED
PMID: 36418515 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DGTS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.